Erratum: Gap junction inhibition prevents drug-induced liver toxicity and fulminant hepatic failure (Nat. Biotechnol. (2012) 30 (179-183) DOI: 10.1038/nbt.2089);Gap junction inhibition prevents drug-induced liver toxicity and fulminant hepatic failure

Nature Biotechnology

Volumn 30, Issue 2, 2012, Pages 179-183

  Patel, Suraj J ^a,b   Milwid, Jack M ^a,b   King, Kevin R ^a   Bohr, Stefan ^a   Iracheta Velle, Arvin ^a   Li, Matthew ^a   Vitalo, Antonia ^a   Parekkadan, Biju ^a   Jindal, Rohit ^c   Yarmush, Martin L ^a,b,c  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^c RUTGERS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACCIDENT PREVENTION; MAMMALS;

CLINICAL MEDICINE; DEVELOPMENT AND APPLICATIONS; FULMINANT HEPATIC FAILURES; GAP JUNCTION PROTEINS; PHARMACEUTICAL INDUSTRY; PHARMACEUTICAL STRATEGIES; SMALL MOLECULE INHIBITOR; THERAPEUTIC COMPOUNDS;

MEDICINE;

2 AMINOETHOXYDIPENYL BORATE; ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; CONNEXIN 32; GASTROINTESTINAL AGENT; PARACETAMOL; REACTIVE OXYGEN METABOLITE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; DEATH; FEMALE; FULMINANT HEPATIC FAILURE; GAP JUNCTION; HELA CELL; HUMAN; HUMAN CELL; LIVER INJURY; LIVER PROTECTION; LIVER TOXICITY; MOUSE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; SURVIVAL; TOXIC HEPATITIS; WILD TYPE;

MUS;

EID: 84863012267     PISSN: 10870156     EISSN: 15461696     Source Type: Journal    
DOI: 10.1038/nbt0314-291c     Document Type: Erratum

References (30)

1. Lee, W.M. Drug-induced hepatotoxicity. N. Engl. J. Med. 349, 474-485 (2003). (Pubitemid 36910027)
2. Kaplowitz, N. Idiosyncratic drug hepatotoxicity. Nat. Rev. Drug Discov. 4, 489-499 (2005). (Pubitemid 40861991)
3. Hutson, S. Painkiller concerns grow ahead of new guidelines. Nat. Med. 16, 10 (2010).
4. Platt, R., Madre, L., Reynolds, R. & Tilson, H. Active drug safety surveillance: a tool to improve public health. Pharmacoepidemiol. Drug Saf. 17, 1175-1182 (2008).
5. Navarro, V.J. & Senior, J.R. Drug-related hepatotoxicity. N. Engl. J. Med. 354, 731-739 (2006). (Pubitemid 43247143)
6. Wysowski, D.K. & Swartz, L. Adverse drug event surveillance and drug withdrawals in the United States, 1969-2002: the importance of reporting suspected reactions. Arch. Intern. Med. 165, 1363-1369 (2005). (Pubitemid 40973418)
7. Lee, W.M. Acetaminophen toxicity: changing perceptions on a social/medical issue. Hepatology 46, 966-970 (2007). (Pubitemid 350144760)
8. Liu, Z.X., Han, D., Gunawan, B. & Kaplowitz, N. Neutrophil depletion protects against murine acetaminophen hepatotoxicity. Hepatology 43, 1220-1230 (2006). (Pubitemid 43980100)
9. Chen, C.J. et al. Identification of a key pathway required for the sterile inflammatory response triggered by dying cells. Nat. Med. 13, 851-856 (2007).
10. Imaeda, A.B. et al. Acetaminophen-induced hepatotoxicity in mice is dependent on Tlr9 and the Nalp3 inflammasome. J. Clin. Invest. 119, 305-314 (2009).
11. Lindros, K.O. Zonation of cytochrome P450 expression, drug metabolism and toxicity in liver. Gen. Pharmacol. 28, 191-196 (1997). (Pubitemid 27016124)
12. Tujios, S. & Fontana, R.J. Mechanisms of drug-induced liver injury: from bedside to bench. Nat Rev Gastroenterol Hepatol 8, 202-211 (2011).
13. Bartolone, J.B., Cohen, S.D. & Khairallah, E.A. Immunohistochemical localization of acetaminophen-bound liver proteins. Fundam. Appl. Toxicol. 13, 859-862 (1989).
14. Segretain, D. & Falk, M.M. Regulation of connexin biosynthesis, assembly, gap junction formation, and removal. Biochim. Biophys. Acta 1662, 3-21 (2004). (Pubitemid 38366510)
15. Patel, S.J., King, K.R., Casali, M. & Yarmush, M.L. DNA-triggered innate immune responses are propagated by gap junction communication. Proc. Natl. Acad. Sci. USA 106, 12867-12872 (2009).
16. Naiki-Ito, A. et al. Gap junction dysfunction reduces acetaminophen hepatotoxicity with impact on apoptotic signaling and connexin 43 protein induction in rat. Toxicol. Pathol. 38, 280-286 (2010).
17. Jaeschke, H. et al. Mechanisms of hepatotoxicity. Toxicol. Sci. 65, 166-176 (2002). (Pubitemid 34121108)
18. Ferret, P.J. et al. Detoxification of reactive oxygen species by a nonpeptidyl mimic of superoxide dismutase cures acetaminophen-induced acute liver failure in the mouse. Hepatology 33, 1173-1180 (2001).
19. Tao, L. & Harris, A.L. 2-aminoethoxydiphenyl borate directly inhibits channels composed of connexin26 and/or connexin32. Mol. Pharmacol. 71, 570-579 (2007). (Pubitemid 46147921)
20. Chun, L.J., Tong, M.J., Busuttil, R.W. & Hiatt, J.R. Acetaminophen hepatotoxicity and acute liver failure. J. Clin. Gastroenterol. 43, 342-349 (2009).
21. Shenton, J.M., Chen, J. & Uetrecht, J.P. Animal models of idiosyncratic drug reactions. Chem. Biol. Interact. 150, 53-70 (2004). (Pubitemid 39441295)
22. Lee, W.M. et al. Intravenous N-acetylcysteine improves transplant-free survival in early stage non-acetaminophen acute liver failure. Gastroenterology 137, 856-864 (2009).
23. Roth, R.A. & Ganey, P.E. Intrinsic versus idiosyncratic drug-induced hepatotoxicity-two villains or one? J. Pharmacol. Exp. Ther. 332, 692-697 (2010).
24. Taha, A.S. et al. Famotidine for the prevention of gastric and duodenal ulcers caused by nonsteroidal antiinflammatory drugs. N. Engl. J. Med. 334, 1435-1439 (1996). (Pubitemid 26157439)
25. Birnbaum, J., Kahan, F.M., Kropp, H. & MacDonald, J.S. Carbapenems, a new class of beta-lactam antibiotics. Discovery and development of imipenem/cilastatin. Am. J. Med. 78, 3-21 (1985). (Pubitemid 15073700)
26. Rohr, S. Role of gap junctions in the propagation of the cardiac action potential. Cardiovasc. Res. 62, 309-322 (2004). (Pubitemid 38496544)
27. Wit, A.L. & Duffy, H.S. Drug development for treatment of cardiac arrhythmias: targeting the gap junctions. Am. J. Physiol. Heart Circ. Physiol. 294, H16-H18 (2008).
28. King, K.R. et al. A high-throughput microfluidic real-time gene expression living cell array. Lab Chip 7, 77-85 (2007). (Pubitemid 44974598)
29. Owusu-Ansah, E., Yavari, A., Mandal, S. & Banerjee, U. Distinct mitochondrial retrograde signals control the G1-S cell cycle checkpoint. Nat. Genet. 40, 356-361 (2008). (Pubitemid 351311760)
30. Porter, W.R. & Neal, R.A. Metabolism of thioacetamide and thioacetamide S-oxide by rat liver microsomes. Drug Metab. Dispos. 6, 379-388 (1978). (Pubitemid 8399686)